NCT07308925Not yet recruiting
Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.
Effectiveness of Using Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
The objective is to compare the efficacy of TR-CGM versus isCGM in patients diagnosed with T2D who are treated with insulin and use CGM, as defined by time in range between 70 and 180 mg/dL. An open-label clinical trial will be conducted. Patients with T2D who use intermittent glucose monitoring and insulin with poor metabolic control will be included. They will be randomized to continue with isCGM or RT-CGM. The primary outcome: %TIR 70-180 mg/dL.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- First submitted
- 20 Sept 2025
- Start date
- 31 Jan 2026
- Primary completion date
- 31 May 2028
- Lead sponsor
- Hospital Universitario San Ignacio
- Diseases
- Type 2 diabetes
- NCT number
- NCT07308925
What you commit to
- Study type: Interventional
- Planned participants: 108
- From 31 Jan 2026 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of bariatric surgery within the year prior to study entry or plans to undergo bariatric surgery during the study.
- Use of medications containing high doses of ascorbic acid (\>2000 mg/day), as it may falsely increase sensor readings.
- Concomitant illness or condition that may compromise patient safety, including, but not limited to, serious mental illness, a diagnosed or suspected eating disorder, or any long-term medical/unmanageable disorder.
Other illness
- Having a condition that would likely require an MRI during the study period.
- Psychiatric condition that interferes with study-related tasks.
- Known (or suspected) significant allergy to medical-grade adhesives.
Lab values
- GFR less than 30 ml/min.
Other
- Pregnancy or planning to become pregnant during the study period.
Who the study is looking for
- Minimum age of 35 years.
- HbA1c \>7.0%
- Treatment with one or more insulin injections.
- Stable medication regimen for the 3 months prior to study entry.
- Insulin treatment for ≥3 months with a stable dose prior to entry, with fasting blood glucose between 70 and 130 mg/dL.
- Availability of an NFC-enabled smartphone.
Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario San Ignacio Coordinator of this site? Confirm its status | Bogotá | Colombia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.